BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36314591)

  • 21. [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients].
    Hanneken S; Rütten A; Eigelshoven S; Braun-Falco M; Pasternack SM; Ruzicka T; Nöthen MM; Betz RC; Kruse R
    Hautarzt; 2011 Nov; 62(11):842-51. PubMed ID: 21971768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?
    Braun-Falco M; Volgger W; Borelli S; Ring J; Disch R
    J Am Acad Dermatol; 2001 Nov; 45(5):760-3. PubMed ID: 11606930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dowling-Degos disease with mutations in POFUT1 is clinicopathologically distinct from reticulate acropigmentation of Kitamura.
    Kono M; Suganuma M; Takama H; Zarzoso I; Saritha M; Bodet D; Aboobacker S; Kaliaperumal K; Suzuki T; Tomita Y; Sugiura K; Akiyama M
    Br J Dermatol; 2015 Aug; 173(2):584-6. PubMed ID: 25639155
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease.
    Li M; Cheng R; Liang J; Yan H; Zhang H; Yang L; Li C; Jiao Q; Lu Z; He J; Ji J; Shen Z; Li C; Hao F; Yu H; Yao Z
    Am J Hum Genet; 2013 Jun; 92(6):895-903. PubMed ID: 23684010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hidradenitis Suppurativa Associated with Galli-Galli Disease: Extending the Link with Dowling-Degos Disease.
    Del Mar M; González M; Sayed C; Phadke P
    J Clin Aesthet Dermatol; 2020 Dec; 13(12):38-40. PubMed ID: 33488918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galli-Galli disease: A case report with review of the literature.
    Gilchrist H; Jackson S; Morse L; Nicotri T; Nesbitt LT
    J Am Acad Dermatol; 2008 Feb; 58(2):299-302. PubMed ID: 18222327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dowling-Degos disease associated with hidradenitis suppurativa: a case report.
    Arjona-Aguilera C; Linares-Barrios M; Albarrán-Planelles C; Jiménez-Gallo D
    Actas Dermosifiliogr; 2015 May; 106(4):337-8. PubMed ID: 25529465
    [No Abstract]   [Full Text] [Related]  

  • 28. [Of hair and genes: The continuing story of Dowling-Degos disease].
    Dereure O
    Ann Dermatol Venereol; 2015 Jan; 142(1):74-5. PubMed ID: 25530071
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of POFUT1 gene mutation in a Chinese family with Dowling-Degos disease.
    Chen M; Li Y; Liu H; Fu X; Yu Y; Yu G; Wang C; Bao F; Liany H; Wang Z; Shi Z; Zhang D; Zhou G; Liu J; Zhang F
    PLoS One; 2014; 9(8):e104496. PubMed ID: 25157627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dowling-Degos syndrome].
    Castellanos-González M; García Martos M; Segurado MA
    Med Clin (Barc); 2015 Jul; 145(1):e1. PubMed ID: 25659864
    [No Abstract]   [Full Text] [Related]  

  • 31. Mast cell activation in Dowling-Degos disease.
    Knuever J; Persa OD; Illerhaus A; Ralser DJ; Hartmann K; Betz RC; Tantcheva-Poór I
    Br J Dermatol; 2019 Dec; 181(6):1312-1314. PubMed ID: 31206596
    [No Abstract]   [Full Text] [Related]  

  • 32. A familial case of Dowling-Degos disease on the vulva.
    Coco V; Guerriero C; Esposito I; De Vincenzo RP; Peris K
    Clin Exp Dermatol; 2019 Dec; 44(8):921-923. PubMed ID: 30666695
    [No Abstract]   [Full Text] [Related]  

  • 33. Genome-wide linkage and exome sequencing analyses identify an initiation codon mutation of KRT5 in a unique Chinese family with generalized Dowling-Degos disease.
    Li M; Wang J; Zhang J; Ni C; Li X; Liang J; Cheng R; Li Z; Yao Z
    Br J Dermatol; 2016 Mar; 174(3):663-6. PubMed ID: 26440693
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered Notch signalling in Dowling-Degos disease: a transcriptomic insight into disease pathogenesis.
    Kumar S; Hausen J; Sivalingam S; Humbatova A; Buness A; Frank J; Ralser DJ; Betz RC
    Br J Dermatol; 2023 Nov; 189(6):772-774. PubMed ID: 37625796
    [No Abstract]   [Full Text] [Related]  

  • 35. Dowling-Degos disease with mutation in the exon 1 of the keratin 5 gene.
    Yu W; Gan L; Wu J; Sun J; Jiang Y
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e14-e15. PubMed ID: 28646612
    [No Abstract]   [Full Text] [Related]  

  • 36. Scrotal Dowling-Degos disease caused by a novel frameshift variant in gamma-secretase subunit presenile enhancer gene.
    Ren J; Zeng LY
    Australas J Dermatol; 2020 Nov; 61(4):e399-e402. PubMed ID: 32478413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Papular acantholytic dyskeratosis of the vulva.
    Roh MR; Choi YJ; Lee KG
    J Dermatol; 2009 Jul; 36(7):427-9. PubMed ID: 19583693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dowling-Degos Disease Presenting With Associated Epidermal Inclusion Cysts: A Case Report and Review of the Literature.
    Marinelli KC; Marinelli LM; Roberts AM; Lincoln MS
    Am J Dermatopathol; 2022 Mar; 44(3):e29-e32. PubMed ID: 34816802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expanding spectrum of Galli-Galli disease.
    El Shabrawi-Caelen L; Rütten A; Kerl H
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S86-91. PubMed ID: 17434047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dowling-Degos disease and chronic hidradenitis suppurativa].
    Rammeh Rommani S; Ajouli W; Fazaa B; Khaled A; Zermani R
    Ann Dermatol Venereol; 2013 Dec; 140(12):838-40. PubMed ID: 24315237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.